Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transcription Factors”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT01577953
What this trial is testing

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 24
Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Not applicableStudy completedNCT03974230
What this trial is testing

Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France.

Who this might be right for
Fuchs Endothelial Corneal Dystrophy
Centre Hospitalier Universitaire de Saint Etienne 208
Testing effectiveness (Phase 2)Looking for participantsNCT07096778
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT02663752
What this trial is testing

A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.

Who this might be right for
Myelodysplastic Syndrome
Novartis Pharmaceuticals 1
Not applicableUnknownNCT04323917
What this trial is testing

Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 850
Early research (Phase 1)Study completedNCT01554319
What this trial is testing

Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 36
Testing effectiveness (Phase 2)Study completedNCT00557609
What this trial is testing

Phase 2 Study in Patients With MiT Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Alveolar Soft Part Sarcoma (ASPS)Clear Cell Sarcoma (CCS)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 47
Testing effectiveness (Phase 2)Looking for participantsNCT06228066
What this trial is testing

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Who this might be right for
Small Cell Carcinoma of the BladderHigh Grade Neuroendocrine Tumors of the Urinary Tract
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)WithdrawnNCT06050512
What this trial is testing

Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Kathleen Dorritie
Large-scale testing (Phase 3)Looking for participantsNCT07772024
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 450
Testing effectiveness (Phase 2)Looking for participantsNCT05918640
What this trial is testing

Lurbinectedin in FET-Fused Tumors

Who this might be right for
Ewing SarcomaDesmoplastic Small Round Cell TumorPediatric Cancer+1 more
Children's Hospital of Philadelphia 63
Very early researchStudy completedNCT01376011
What this trial is testing

Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement

Who this might be right for
StrokeProblem of Aging
Brigham and Women's Hospital 106
Testing effectiveness (Phase 2)Study completedNCT02129439
What this trial is testing

Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients

Who this might be right for
Colitis, Ulcerative
Sterna Biologicals GmbH & Co. KG 20
Early research (Phase 1)Study completedNCT00080392
What this trial is testing

EW-A-401 to Treat Intermittent Claudication

Who this might be right for
Intermittent ClaudicationArteriosclerosis
National Heart, Lung, and Blood Institute (NHLBI) 10
Very early researchStudy completedNCT02557958
What this trial is testing

Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

Who this might be right for
Chronic Obstructive Pulmonary Disease
NYU Langone Health 19
Early research (Phase 1)Looking for participantsNCT07363395
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults

Who this might be right for
Neuropathic Pain
Alcamena Stem Cell Therapeutics 72
Not applicableStudy completedNCT06029634
What this trial is testing

Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients

Who this might be right for
Chronic HBV InfectionDrug Withdrawal
Changhai Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT06785636
What this trial is testing

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)Prostate Cancer
Pathos AI, Inc. 120
Early research (Phase 1)Study completedNCT01470911
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 46
Next Page